SCHEMBL333015

SCHEMBL333015

CC(C)CCOC(=O)CCC(=O)OCCC(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.50
ADRA1A P35348 1/20 0.50
CYP19A1 P11511 1/20 0.50
MAPT P10636 1/20 0.48
BLM P54132 1/20 0.48
CA1 P00915 3/20 0.46
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
TDP1 Q9NUW8 2/20 0.44
DGKA P23743 1/20 0.41
MAPK1 P28482 2/20 0.41
ALDH1A1 P00352 2/20 0.41
PKM P14618 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.40
EPHX2 P34913 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4292777 0.93 CYP19A1 (0.49) ADRA2AADRA1ACYP19A1MAPTBLM
SCHEMBL27603905 0.91 CYP1A2 (0.45) ADRA2AADRA1ACYP19A1MAPTBLM
SCHEMBL13575623 0.91 CYP19A1 (0.45) ADRA2AADRA1ACYP19A1MAPTBLM
SCHEMBL527566 0.91 CYP19A1 (0.45) ADRA2AADRA1ACYP19A1MAPTBLM
SCHEMBL249563 0.91 DGKA (0.54) ADRA2AADRA1ACYP19A1MAPTBLM
SCHEMBL14672499 0.91 DGKA (0.48) ADRA2AADRA1ACYP19A1MAPTBLM
SCHEMBL19822812 0.89 LMNA (0.46) ADRA2AADRA1ACYP19A1MAPTBLM
SCHEMBL27523015 0.89 CYP19A1 (0.44) ADRA2AADRA1ACYP19A1MAPTBLM
SCHEMBL2701641 0.89 CYP19A1 (0.44) ADRA2AADRA1ACYP19A1MAPTBLM
SCHEMBL247200 0.89 DGKA (0.57) CYP19A1MAPTCA1CA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119656881-B Reverse osmosis membrane with coralloid structure and preparation method and application thereof 苏州实验室 2025-05-23 CN claimed
CN-119656881-A Reverse osmosis membrane with coralloid structure and preparation method and application thereof 苏州实验室 2025-03-21 CN claimed
CN-118530412-A Binder for negative electrode, negative electrode slurry, negative electrode, and lithium battery 深圳好电科技有限公司 2024-08-23 CN claimed
CN-110724523-B Water-soluble fluorescent probe with tumor targeting function, synthetic method and application thereof 德州学院 2022-11-29 CN claimed
US-11274214-B2 Composition of water based coating with a low content of volatile organic compounds and high resistance to dirt handle, and, use of water based coating OXITENO S.A. INDÚSTRIA E COMÉRCIO (BR) 2022-03-15 US claimed
CN-110724523-A Water-soluble fluorescent probe with tumor targeting function, synthetic method and application thereof 德州学院 2020-01-24 CN claimed
CN-105566520-A Catalyst component for olefin polymerization and catalyst comprising catalyst component CHINA PETROLEUM & CHEM CORP 2016-05-11 CN claimed
CN-104119559-A Boron mud used for reinforced corrugated pipe materials and preparing method thereof HEFEI HEAN MACHINERY MFG CO LTD 2014-10-29 CN claimed
US-20260146267-A1 BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF Zhuhai Kingfa Biomaterial Co., Ltd. (CN) 2026-05-28 US disclosed
US-20260146126-A1 SUCCINIC ACID COMPOSITION, POLYESTER PREPARED THEREFROM, AND POLYESTER COMPOSITE MATERIAL Zhuhai Kingfa Biomaterial Co., Ltd. (CN) 2026-05-28 US disclosed
US-20260146129-A1 BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND POLYESTER PREPARED THEREFROM SHANGHAI KINGFA SCIENCE & TECHNOLOGY CO., LTD. (CN) 2026-05-28 US disclosed
EP-4748822-A2 BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF Zhuhai Kingfa Biomaterial Co., Ltd. (CN) 2026-05-27 EP disclosed
EP-4748872-A1 SUCCINIC ACID COMPOSITION, POLYESTER PREPARED THEREFROM, AND POLYESTER COMPOSITE MATERIAL Zhuhai Kingfa Biomaterial Co., Ltd. (CN) 2026-05-27 EP disclosed
EP-4748823-A1 BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND POLYESTER PREPARED THEREFROM Shanghai Kingfa Science & Technology Co., Ltd (CN) 2026-05-27 EP disclosed
WO-1992009195-A1 HERBICIDAL COMPOSITIONS KVK AGRO A/S (DK) 1992-06-11 WO disclosed
US-5100697-A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD CASTROL A/S (DK) 1992-03-31 US disclosed
EP-0180630-B1 A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD CASTROL A/S (DK) 1991-10-09 EP disclosed
EP-0328158-A1 A method for improving the release of a cast concrete item from the mould by applying to the mould a mould release composition CASTROL A/S (DK) 1989-08-16 EP disclosed
EP-0180630-A1 A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD. KOEGE KEMISK VAERK (DK) 1986-05-14 EP disclosed
WO-1985005066-A1 A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD KEMISK VA^ERK KO^/GE A/S (DK) 1985-11-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260146267-A1 BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF SUCLA2, SUCLG2, LDHA ADRA2A 3738/4885ADRA1A 3293/4885CYP19A1 183/4885
US-20260146126-A1 SUCCINIC ACID COMPOSITION, POLYESTER PREPARED THEREFROM, AND POLYESTER COMPOSITE MATERIAL MTOR, RICTOR, SQSTM1 ADRA2A 4630/4885ADRA1A 4748/4885CYP19A1 702/4885
US-20260146129-A1 BIO-BASED SUCCINIC ACID COMPOSITION, PREPARATION METHOD THEREFOR, AND POLYESTER PREPARED THEREFROM SUCLA2, SUCNR1, SUCLG2 ADRA2A 4636/4885ADRA1A 4511/4885CYP19A1 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.